Atlas Trials

Ponatinib for Advanced Medullary Thyroid Cancer

Clinical trial NCT01838642 · TERMINATED

Trial details

NCT number
NCT01838642
Sponsor
National Institutes of Health Clinical Center (CC)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Neoplasms
Start date
2013-03-01
Primary completion
2015-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.